Inhibition of the miR-143/145 cluster attenuated neutrophil differentiation of APL cells

Leuk Res. 2012 Feb;36(2):237-40. doi: 10.1016/j.leukres.2011.10.006. Epub 2011 Nov 16.

Abstract

MicroRNAs can influence hematopoietic cell lineage commitment and aberrant expression of hematopoietic miRNAs contributes to AML pathology. We found that miR-143 and miR-145 expression is significantly repressed in primary AML patient samples as compared to neutrophils of healthy donors. Further analysis revealed impaired neutrophil differentiation of APL cells upon inhibition of miR-145 expression. Lastly, we identified p73 as transcriptional regulator of miR-143/145 during neutrophil differentiation of APL cells. Our data suggest that low miR-145 levels in APL, possibly due to aberrant expression of p73 transcription factors, contribute to the differentiation block seen in this disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Cell Differentiation*
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Leukemia, Myeloid, Acute / genetics*
  • MicroRNAs / antagonists & inhibitors
  • MicroRNAs / genetics*
  • Neutrophils / metabolism
  • Neutrophils / pathology*
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Promoter Regions, Genetic / genetics
  • Real-Time Polymerase Chain Reaction
  • Tretinoin / pharmacology
  • Tumor Cells, Cultured
  • Tumor Protein p73
  • Tumor Suppressor Proteins / genetics
  • Tumor Suppressor Proteins / metabolism

Substances

  • Antineoplastic Agents
  • DNA-Binding Proteins
  • MIRN143 microRNA, human
  • MIRN145 microRNA, human
  • MicroRNAs
  • Nuclear Proteins
  • TP73 protein, human
  • Tumor Protein p73
  • Tumor Suppressor Proteins
  • Tretinoin